|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.750 GBX | -0.51% |
|
-3.94% | -17.02% |
| 06-10 | Ixico cheers FDA approval for contractor Fujirebio's Alzheimer's test | AN |
| 06-10 | IXICO plc Announces FDA Clearance of New Alzheimer's Disease Blood Based Diagnostic Biomarker | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bullish | Neutral |
| Resistance | 11.25 | 13 | 12.75 |
| Spread/Res. | -13.33% | -25.00% | -23.53% |
| Spread/Supp. | +0.52% | +0.52% | +39.29% |
| Support | 9.7 | 9.7 | 7 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- IXI Stock
- Charts IXICO plc
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition